Table 4.1.
Summary of institutional guidelines for laboratory testing of oocyte donors
| FDA [8] | ASRM [7] | NYSDHa | |
|---|---|---|---|
| ABO and Rh type | X | X | |
| HIV-1 and HIV-2 | X | X | X |
| Hepatitis B core antibody | X | X | |
| Hepatitis B surface antigen | X | X | X |
| Hepatitis C antibody | X | X | X |
| Human T-lymphotropic virus (type 1) | X | ||
| Syphilis | X | X | X |
| Chlamydia | X | X | X |
| Gonorrhea | X | X | X |
| West Nile virus | X |
FDA US Food and Drug Administration, ASRM American Society for Reproductive Medicine, NYSDH New York State Department of Health
aReproductive Tissue Banks. Part 52 of Title 10 (health) of the official compilation of codes, rules and regulations of the state of New York 2007; Subpart 52–8:64–74